TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/23/24 17:23 | 4/22/24 | KRRO | Korro Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Atlas Venture Opportunity Fund Ii, L.P. | MA | T | P | 1,000 | 56.00 | 0 | 18 | 10 | 195 | D | |||||||||||||||
12/14/22 16:55 | 12/12/22 | DYN | Dyne Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Atlas Venture Opportunity Fund Ii, L.P. | MA | T | P | 10,000 | 10.70 | 0 | 935 | 10 | 9,869 | D | |||||||||||||||
6/22/22 17:09 | 6/17/22 | DAWN | Day One Biopharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Atlas Venture Opportunity Fund Ii, L.P. | MA | T | P | 11,500 | 15.00 | 0 | 767 | 9 | 8,984 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |